Ignite Creation Date:
2025-12-24 @ 3:40 PM
Ignite Modification Date:
2026-01-22 @ 1:39 PM
Study NCT ID:
NCT02516592
Status:
COMPLETED
Last Update Posted:
2019-03-21
First Post:
2015-08-04
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Assessment of Switching From Salmeterol/Fluticasone to Indacaterol/Glycopyrronium in a symtomaticCOPD Patient Cohort
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-10-13
Start Date Type:
ACTUAL
Primary Completion Date:
2017-05-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-05-04
Completion Date Type:
ACTUAL
First Submit Date:
2015-08-04
First Submit QC Date:
None
Study First Post Date:
2015-08-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-04-23
Results First Submit QC Date:
None
Results First Post Date:
2019-03-21
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-12-11
Last Update Post Date:
2019-03-21
Last Update Post Date Type:
ACTUAL